Response to bortezomib in newly diagnosed multiple myeloma- a single centre experience from India

被引：0
|
作者：
Rajan, V. [1 ]
N, G. [1 ]
Nair, S. G. [1 ]
机构：
[1] Reg Canc Ctr Thiruvananthapuram Trivandrum, Med Oncol, Thiruvananthapuram, Kerala, India
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
305P
引用
收藏
页码：90 / 90
页数：1
相关论文
共 50 条
  • [1] Bortezomib in newly diagnosed multiple myeloma
    James R. Berenson
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 255 - 256
  • [2] Bortezomib in newly diagnosed multiple myeloma
    Berenson, James R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 255 - 256
  • [3] Optimising bortezomib in newly diagnosed multiple myeloma
    Rajkumar, S. Vincent
    [J]. LANCET ONCOLOGY, 2010, 11 (10): : 909 - 910
  • [4] Bortezomib in newly diagnosed patients with multiple myeloma: A retrospective analysis from a tertiary care center in India
    Pragnya, C.
    Linga, V. G.
    Thota, N. K.
    Gundeti, S.
    Digumarti, R.
    [J]. INDIAN JOURNAL OF CANCER, 2015, 52 (04) : 537 - 540
  • [5] OUTCOME OF NEWLY DIAGNOSED SYMTOMATIC MULTIPLE MYELOMA IN PATIENTS AGED > 80 YEARS: SINGLE CENTRE EXPERIENCE
    Sgherza, N.
    Minoia, C.
    Iacobazzi, A.
    Rana, A.
    Lapietra, A.
    Loseto, G.
    De Fazio, V.
    De Tullio, G.
    Serrat, S.
    Guarini, A.
    [J]. HAEMATOLOGICA, 2014, 99 : 641 - 641
  • [6] Autologous Stem Cell Transplantation in Newly Diagnosed Elderly Multiple Myeloma Patients: A Single Centre Experience
    Berno, Tamara
    Riva, Marcello
    Ammirati, Lucia
    Brugnaro, Luca
    Gurrieri, Carmela
    Branca, Antonio
    Mitja, Nabergoj
    Visentin, Andrea
    Imbergamo, Silvia
    Piazza, Francesco
    Trentin, Livio
    Zambello, Renato
    Semenzato, Gianpietro
    [J]. BLOOD, 2017, 130
  • [7] A SINGLE CENTRE EXPERIENCE OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS
    Riva, M.
    Ammirati, L.
    Visentin, A.
    Gurrieri, C.
    Branca, A.
    Scapinello, G.
    Barila, G.
    Imbergamo, S.
    Piazza, F.
    Trentin, L.
    Zambello, R.
    Semenzato, G.
    Berno, T.
    [J]. HAEMATOLOGICA, 2019, 104 : 166 - 166
  • [8] Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma
    Laubach, Jacob P.
    Schlossman, Robert L.
    Mitsiades, Constantine S.
    Anderson, Kenneth C.
    Richardson, Paul G.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2011, 4 (01) : 51 - 60
  • [9] Bortezomib Plus Thalidomide for Newly Diagnosed Multiple Myeloma in China
    Chen, Shi-Lun
    Jiang, Bin
    Qiu, Lu-Gui
    Yu, Li
    Zhong, Yu-Ping
    Gao, Wen
    [J]. ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2010, 293 (10): : 1679 - 1684
  • [10] Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
    Zafar, Mir Sadaqat Hassan
    Khan, Afaq Ahmed
    Aggarwal, Shyam
    Bhargava, Manorama
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) : 58 - 60
12345